Charles River Laboratories CRL Deferred revenue, net of current portion
Deferred revenue, net of current portion at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's deferred revenue, net of current portion.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's deferred revenue, net of current portion?
- Charles River Laboratories (CRL) reported deferred revenue, net of current portion of $47.06M in Q1 2026.
- How has Charles River Laboratories's deferred revenue, net of current portion changed year-over-year?
- Charles River Laboratories's deferred revenue, net of current portion increased by 38.6% year-over-year, from $33.95M to $47.06M.
- What is the long-term trend for Charles River Laboratories's deferred revenue, net of current portion?
- Over 4 years (2020 to 2025), Charles River Laboratories's deferred revenue, net of current portion has grown at a 23.7% compound annual growth rate (CAGR), from $19.48M to $45.63M.